Home Health and Hospice M&A Report: Q2 2019 August 22, 2019 DOWNLOAD PDF Hospice Drives Q2 Transaction ActivityAfter a somewhat down first quarter of 2019, home health, home care and hospice M&A transaction activity rebounded strongly in Q2. Unsurprisingly, the rebound was largely driven by hospice demand, though home [...]
Behavioral Health M&A Report: Q2 2019 Download PDF August 22, 2019 Behavioral health transaction activity regained some momentum in the second quarter of 2019, the latest data from M&A advisory firm Mertz Taggart shows. Each of the specialties bounced back in earnest after a slower Q1, with addiction [...]
7 Ways to Maximize the Value of Your Hospice August, 2019 The hospice mergers and acquisitions environment has never been more robust, with valuations reaching record levels and buyers hungry for assets of all sizes.Unlike the Patient-Driven Groupings Model (PDGM) uncertainty that the home health industry currently faces, the [...]
Home Health, Hospice and Home Care M&A Report: Q1 2019 May 28, 2019 As expected, the first quarter of 2019 saw a slight dip in home health, hospice and home care dealmaking activity, the latest data from M&A advisory firm Mertz Taggart show. The drop in total transactions [...]
The Patient-Driven Groupings Model (PDGM) — set for a Jan. 1, 2020 implementation date — is the most significant change the home health industry has seen...
2018 was a booming year for health care M&A activity. Of the home health, hospice and home care segments, the home health industry saw the greatest number of total transactions in both 2017 and 2018.
2018 was a banner year for mergers & acquisitions in the home health, private duty home care, and hospice industries. We saw more deals announced and closed than any year in recent history.
For hospice organizations looking to sell, the market has never been hotter. That is, of course, if a seller has all of its clinical records and compliance documentation in order.
This is, in fact, the first time in more than a decade that home health, home care and hospice are all selling at relative high valuations.
There has been much talk lately about M&A activity in the addiction treatment industry, prompting questions from many practitioners about the process of valuing and selling a treatment center.